NEXT Oncology
Shiraj S. is a highly experienced medical professional with a background in oncology research and clinical practice. Currently serving as Phase 1 Clinical Investigator and Director of Clinical Research at NEXT Oncology San Antonio and as a Medical Oncologist at Texas Oncology, Shiraj has also held key positions at Genentech, Sarah Cannon Research Institute, MD Anderson Cancer Center, and UT Southwestern Medical Center. With an M.D., Ph.D. from The University of Texas Health Science Center at Houston and a B.A. from The University of Texas at Austin, Shiraj brings a wealth of knowledge and expertise to the field of oncology.
This person is not in any offices
NEXT Oncology
NEXT Oncology, founded by Anthony W. Tolcher, M.D., FRCPC, is a Phase 1 center dedicated to providing options for advanced cancer patients and advancing cancer research. Dr. Tolcher’s passion for research and the community lays the foundation for an international brand committed to finding the next breakthrough. Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT. He is dedicated to the development of new anticancer agents for patients whose current cancer therapy is no longer working to benefit them and are looking for their next option that includes clinical trials of new agents and therapies. Dr. Tolcher is proud that at NEXT Oncology the team scours the world to bring the best new agents back to our patients and centers. This is not a job for Dr. Tolcher, it is his passion.